Canada’s Drug Agency (CDA-AMC), on behalf of its time-limited Essential Prescription Drugs and Related Products Advisory Panel, is inviting interested parties to provide input on the processes used for including and excluding products, the recommended approach to updating the proposed list of essential prescription drugs and related products over time, and identifying potential commonly prescribed drugs and related products used in Canada and not already considered by the advisory panel to be included in preparation of the proposed list. Your comments will be used to inform a final report that will be submitted to Health Canada, shared with provincial and territorial governments, and made publicly available.
Instructions and Consent
You are welcome to respond to the questions. The consultation period will close on July 18, 2025. This questionnaire will take approximately 30 minutes to complete. You will not need to complete it at one time. You can save your draft responses before submitting them to us. Please note that you must not use “in private” or “incognito” mode on your web browser to be able to return to your previous draft responses.
To encourage conversation on this topic and ensure transparency, CDA-AMC will publish the comments throughout this engagement process. By submitting your written comments to CDA-AMC, you, or the organization you represent agree to the full disclosure of the information. CDA-AMC will not edit or validate your feedback or review any references or links you include for accuracy or with respect to content. CDA-AMC reserves the right to refuse to post feedback, in whole or in part, that, in its sole discretion, it deems to be unrelated to the issue under consultation; contains complaints and/or compliments about identifiable individuals; contains personal identifiers and/or other information that may identify a third party; is abusive, obscene, harassing, threatening or otherwise inappropriate.
If you have any questions about this consultation process, please email us at [email protected]